Research programme: alkaloid-conjugate analgesics - ChimeracomAlternative Names: Chimeric hybrid molecules; Hybrid chimera
Latest Information Update: 31 Oct 2007
At a glance
- Originator Chimeracom LLC
- Mechanism of Action Neurokinin 1 receptor agonists; Opioid mu receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Pain
Most Recent Events
- 31 Oct 2007 Preclinical development is ongoing
- 25 Aug 2005 Preclinical trials in Pain in USA (unspecified route)